Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gephart J. F., Washington J. A., 2nd Antimicrobial susceptibilities of nutritionally variant streptococci. J Infect Dis. 1982 Oct;146(4):536–539. doi: 10.1093/infdis/146.4.536. [DOI] [PubMed] [Google Scholar]
- Gray I. R. Management of infective endocarditis. J R Coll Physicians Lond. 1981 Jul;15(3):173–178. [PMC free article] [PubMed] [Google Scholar]
- Guntheroth W. G., Cammarano A. A., Kirby W. M. Home treatment of infective endocarditis with oral amoxicillin. Am J Cardiol. 1985 Apr 15;55(9):1231–1232. doi: 10.1016/0002-9149(85)90674-5. [DOI] [PubMed] [Google Scholar]
- Karchmer A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. doi: 10.1016/0002-9343(85)90374-2. [DOI] [PubMed] [Google Scholar]
- Levine D. P., Cushing R. D., Jui J., Brown W. J. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med. 1982 Sep;97(3):330–338. doi: 10.7326/0003-4819-97-3-330. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Srulevitch E. S., Jacobson J., Hirschman S. Z. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrob Agents Chemother. 1983 Nov;24(5):812–814. doi: 10.1128/aac.24.5.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oikawa J. H., Kaye D. Endocarditis: epidemiology, pathophysiology, management, and prophylaxis. Cardiovasc Clin. 1986;16(2):335–357. [PubMed] [Google Scholar]
- Richardson J. V., Karp R. B., Kirklin J. W., Dismukes W. E. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation. 1978 Oct;58(4):589–597. doi: 10.1161/01.cir.58.4.589. [DOI] [PubMed] [Google Scholar]
- Roberts R. B., Krieger A. G., Schiller N. L., Gross K. C. Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci. Rev Infect Dis. 1979 Nov-Dec;1(6):955–966. doi: 10.1093/clinids/1.6.955. [DOI] [PubMed] [Google Scholar]
- Shanson D. C., Ashford R. F., Singh J. High-dose oral amoxycillin for preventing endocarditis. Br Med J. 1980 Feb 16;280(6212):446–446. doi: 10.1136/bmj.280.6212.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shanson D. C., McNabb R., Hajipieris P. The effect of probenecid on serum amoxycillin concentrations up to 18 hours after a single 3 g oral dose of amoxycillin: possible implications for preventing endocarditis. J Antimicrob Chemother. 1984 Jun;13(6):629–632. doi: 10.1093/jac/13.6.629. [DOI] [PubMed] [Google Scholar]
- Stoeckel K., McNamara P. J., Brandt R., Plozza-Nottebrock H., Ziegler W. H. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther. 1981 May;29(5):650–657. doi: 10.1038/clpt.1981.90. [DOI] [PubMed] [Google Scholar]
- Verbist L., Tjandramaga B., Hendrickx B., Van Hecken A., Van Melle P., Verbesselt R., Verhaegen J., De Schepper P. J. In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother. 1984 Dec;26(6):881–886. doi: 10.1128/aac.26.6.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson W. R., Geraci J. E. Treatment of streptococcal infective endocarditis. Am J Med. 1985 Jun 28;78(6B):128–137. doi: 10.1016/0002-9343(85)90375-4. [DOI] [PubMed] [Google Scholar]
- Wilson W. R., Giuliani E. R., Geraci J. E. Treatment of penicillin-sensitive streptococcal infective endocarditis. Mayo Clin Proc. 1982 Feb;57(2):95–100. [PubMed] [Google Scholar]